Circulating immune complexes do not affect microparticle flow cytometry analysis in acute coronary syndrome

Blood

Volumn 119, Issue 9, 2012, Pages 2174-2175

  Amabile, Nicolas ^a   Renard, Jean Marie ^a   Caussin, Christophe ^b   Boulanger, Chantal M ^a  

^a INSERM   (France)

^b CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOCORTIN 5; TYLOXAPOL;

ACUTE CORONARY SYNDROME; ANTIGEN ANTIBODY COMPLEX; CARDIAC PATIENT; CORONARY ARTERY DISEASE; FLOW CYTOMETRY; HUMAN; LETTER; MEMBRANE MICROPARTICLE; PRIORITY JOURNAL; SYNOVIAL FLUID; THROMBOCYTE FREE PLASMA;

EID: 84857760285     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-11-393181     Document Type: Letter

References (5)

1. Freyssinet JM, Toti F. Membrane microparticle determination: at least seeing what's being sized! J Thromb Haemost. 2010;8(2):311-314.
2. Williams JC, Mackman N. MPs or ICs? Blood. 2011;117(4):1101-1102.
3. Gyorgy B, Modos K, Pallinger E, et al. Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters. Blood. 2011;117(4):e39-e48.
4. Lefvert AK, Hamsten A, Holm G. Association between circulating immune complexes, complement C4 null alleles, and myocardial infarction before age 45 years. Arterioscler Thromb Vasc Biol. 1995;15(5):665-668.
5. Amabile N, Guerin AP, Leroyer A, et al. Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. J Am Soc Nephrol. 2005;16(11):3381-3388. (Pubitemid 46179341)